Physician profile
Samira Sheth
NPI 1245369925
$1,918.86
in general payments reported to CMS, 2019-2025
6 companies · $1,524 in 2025
The $1,524 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $179 · 2024: $216 · 2025: $1,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,156 · Food and Beverage: $721 · Education: $41.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,156.00 |
| Food and Beverage | $721.14 |
| Education | $41.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $1,484.78 | 2023-2025 | Entyvio |
| Abbvie INC. | $139.97 | 2023-2025 | |
| Genzyme Corporation | $126.98 | 2025 | |
| Janssen Biotech, INC. | $124.48 | 2024 | Tremfya, Stelara |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | |
| Pfizer INC. | $16.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samira Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.